Findings for genetically predicted IGF‐1 levels in relation to prostate and breast cancer were inconsistent with a suggestive positive association observed only in UK Biobank (for prostate cancer) or the BCAC (for breast cancer), or when using the SNP in the IGF1 gene as instrument (for prostate cancer). The gene discussed is IGF1; the disease is prostate carcinoma.